Literature DB >> 9780158

Positive and negative regulation of human T cell activation mediated by the CTLA-4/CD28 ligand CD80.

G Boulougouris1, J D McLeod, Y I Patel, C N Ellwood, L S Walker, D M Sansom.   

Abstract

CD28 and CTLA-4 are related receptors that differentially regulate T cell activation. Despite the fact that they bind the same ligands, CD28 is a classical costimulator enhancing proliferation whereas CTLA-4 appears to perform negative regulatory functions. In this study, we have utilized the natural ligand for CD28 and CTLA-4 (CD80) to determine under what circumstances positive and negative effects are operative. We show here that the stimulation of purified human T cells with phorbol ester and ionomycin is inhibited in the presence of Chinese hamster ovary (CHO) cells expressing CD80. This inhibition is reversed by blocking with both anti-CD80 or Fab fragments of anti-CTLA-4 but also requires CD28 engagement. Furthermore, we show that the inhibitory function of CD80 requires elevated intracellular calcium since inhibition was observed only in the presence of ionomycin. In the absence of intracellular calcium elevation, CTLA-4 was not expressed at the cell surface, and CD80 acted positively as a costimulator of T cells, via CD28. These results demonstrate that the natural ligand CD80 can either costimulate or inhibit T cell responses depending on the conditions of T cell stimulation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9780158

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Single-nucleotide polymorphisms in the B7H3 gene are not associated with human autoimmune myasthenia gravis.

Authors:  Priya Sakthivel; Xiongbiao Wang; Baback Gharizadeh; Ricardo Giscombe; Ritva Pirskanen; Pål Nyren; Ann Kari Lefvert
Journal:  J Genet       Date:  2006-12       Impact factor: 1.166

2.  Polymorphisms in PDCD1 gene are not associated with Wegener's granulomatosis.

Authors:  Priya Sakthivel; Ricardo Giscombe; Ryan Ramanujam; Ann Kari Lefvert
Journal:  Rheumatol Int       Date:  2009-05-18       Impact factor: 2.631

3.  Force-dependent trans-endocytosis by breast cancer cells depletes costimulatory receptor CD80 and attenuates T cell activation.

Authors:  Seungman Park; Yu Shi; Byoung Choul Kim; Myung Hyun Jo; Leilani O Cruz; Zheming Gou; Taekjip Ha; Li-Fan Lu; Daniel H Reich; Yun Chen
Journal:  Biosens Bioelectron       Date:  2020-06-17       Impact factor: 10.618

4.  Disparate effects of phorbol esters, CD3 and the costimulatory receptors CD2 and CD28 on RANTES secretion by human T lymphocytes.

Authors:  Y Sotsios; P J Blair; J Westwick; S G Ward
Journal:  Immunology       Date:  2000-09       Impact factor: 7.397

5.  Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management.

Authors:  Ye H Oo; Stefan G Hubscher; David H Adams
Journal:  Hepatol Int       Date:  2010-05-19       Impact factor: 6.047

6.  Effects of superantigen and lipopolysaccharide on induction of CD80 through apoptosis of human monocytes.

Authors:  M Takahashi; M Takahashi; F Shinohara; H Takada; H Rikiishi
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

Review 7.  The Role of the Immune System in the Development of Endometriosis.

Authors:  Monika Abramiuk; Ewelina Grywalska; Paulina Małkowska; Olga Sierawska; Rafał Hrynkiewicz; Paulina Niedźwiedzka-Rystwej
Journal:  Cells       Date:  2022-06-25       Impact factor: 7.666

8.  Impaired proteasome function activates GATA3 in T cells and upregulates CTLA-4: relevance for Sézary syndrome.

Authors:  Heather M Gibson; Anjali Mishra; Derek V Chan; Timothy S Hake; Pierluigi Porcu; Henry K Wong
Journal:  J Invest Dermatol       Date:  2012-09-06       Impact factor: 8.551

9.  Autoimmune hepatitis as a unique form of an autoimmune liver disease: immunological aspects and clinical overview.

Authors:  Hind I Fallatah; Hisham O Akbar
Journal:  Autoimmune Dis       Date:  2012-12-12

10.  Inhibition of B7-1 (CD80) by RhuDex® reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesions.

Authors:  Andreas O Doesch; Li Zhao; Christian A Gleissner; Mohammadreza Akhavanpoor; David Rohde; Deniz Okuyucu; Maani Hakimi; Thomas J Dengler; Hugo A Katus; Christian Erbel
Journal:  Drug Des Devel Ther       Date:  2014-05-12       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.